Curcumin for adults with sepsis in the ICU
Treatments studied
Part of Infections clinical trials.
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis and are in the ICU at the study hospital
- You are getting nutrition through a feeding tube
- You or your family can sign a consent form
- You are not allergic to turmeric or curcumin
- You do not have a condition that prevents you from using a feeding tube
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This study tests whether a special form of vitamin D can improve outcomes for patients with sepsis, a severe infection that can cause organ failure. The treatment is given to patients in the intensive care unit, and the study aims to see if it helps them recover better.
This study tests whether fenofibrate (a cholesterol medicine) or silymarin (an herbal extract) can help adults with sepsis recover. You may need to be in the hospital with an active infection to participate.
This trial is testing several different treatments to find the best one for each person with sepsis. It looks at specific 'treatable traits' like inflammation, blood clotting problems, or immune system issues to match you with the right therapy. The goal is to improve recovery and survival.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.